Navigation Links
Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
Date:5/2/2013

NEW BRUNSWICK, N.J., May 2, 2013 /PRNewswire/ -- Janssen R&D Ireland (Janssen) and Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast for investors and other interested parties on Friday, May 3, at approximately 8:30 a.m., Eastern Time, to discuss simeprevir phase 3 clinical data presented at The International Liver Congress of the European Association for the Study of the Liver (EASL).

A pre-recorded webcast featuring management from Janssen will provide an overview of results from the phase 3 QUEST -1 and QUEST-2 studies of the investigational protease inhibitor simeprevir (TMC435) administered once daily in combination with pegylated interferon and ribavirin in treatment-naive genotype 1 chronic hepatitis C patients.

The webcast/podcast can be accessed by visiting the Johnson & Johnson website at www.investor.jnj.com and clicking on "Webcasts/Presentations."

 

 


'/>"/>
SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
2. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
3. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
4. Janssen Pharmaceutica, NV, Funds New Global Mental Health Scholarships as Part of Its Healthy Minds Program
5. Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
6. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
7. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
8. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
9. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
10. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
11. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Boston Scientific Corporation (NYSE: BSX ... purchase the Interventional business of Bayer AG. The ... offer physicians and healthcare systems a more complete ... The addition of the Bayer Interventional ... Boston Scientific strategy to provide a comprehensive portfolio ...
(Date:9/2/2014)... , Sept. 2, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... participating in the Morgan Stanley Healthcare conference on ... Scott Huennekens , president and chief executive ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014  Arena ... that the US Food and Drug Administration (FDA) has ... of pulmonary arterial hypertension. "The FDA ... clinical data submissions from sponsors to identify and designate ... help advance the evaluation and development of such products," ...
Breaking Medicine Technology:Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 2Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 3Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 5Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4
... successfully enticed one of the best known professionals in emergency medical care ... Dan White , formerly of AllMed , ... subsidiary of Truphatek http://www.truphatek.com/ . ... reached after this week at 573-240-0002 or by e-mail at ...
... 6 Extending its reach into more international high-tech ... has signed Semiconductor Parts and Materials ... components and provide local applications support throughout Europe. Applied ... ultraclean manufacturing of semiconductors, solar cells and pharmaceutical products. ...
Cached Medicine Technology:New Places and People - Truphatek opens USA subsidiary 2New Places and People - Truphatek opens USA subsidiary 3Applied Seals North America Extends Global Network With Addition of Distributor in Europe 2
(Date:9/2/2014)... Doheny HealthDay Reporter TUESDAY, ... is a driving force behind the rising rates of type ... at data from five national surveys spanning from 1976 through ... time could be explained by factors such as changing distribution ... investigators found that the prevalence of diabetes in men rose ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, Sept. 2, ... weight loss by blocking a certain nerve linked to appetite ... obese patients. Using electric impulses to block the vagus ... to suppress feelings of hunger. And, they did, just not ... blocks the nerve that connects the brain to the gut ...
(Date:9/2/2014)... (Sept. 2, 2014) Measuring the levels of sex hormones ... sudden cardiac arrest, a heart rhythm disorder that is fatal ... published online by the peer-reviewed journal Heart Rhythm , ... hormone, were found in men who had a sudden cardiac ... were strongly associated with greater chances of having a sudden ...
(Date:9/2/2014)... 02, 2014 Evolve Medical Clinics, ... primary and urgent care arena, is having its ... with a health fair the clinic is sponsoring. ... to assist patients in achieving high quality, convenient ... pricing structure is a groundbreaking change in healthcare. ...
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... soccer tickets. The first week in September will be ... Teams from Brazil, Colombia, Mexico, Chile, Ecuador and Bolivia ... The following matches will take place between September 5th - ... Stadium on Tuesday, September 9th , Mexico vs. ...
Breaking Medicine News(10 mins):Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 2Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 3Health News:Study links sex hormone levels in the blood to risk of sudden cardiac arrest 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3
... Brun, fierce mental health advocate for hurricane-traumatized children, is ... Sister Judith Brun, CSJ, who has worked tirelessly to ... still suffering hurricane-induced trauma in Louisiana, will address the ... Commencement on June 7. , , Brun,s ...
... , , HAE:TSX, ... , MONTREAL, June 3 /PRNewswire-FirstCall/ - Haemacure Corporation ... and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX:ANP) ... Angiotech to Haemacure in a minimum amount of US$2.5 ...
... The SSI Group, Inc. (SSI) announced their success in ... Health System (DUHS) and its affiliated hospitals for a ... the primary supplier of claims management products, including but not ... functionality of posting back billing information to the host HIS ...
... A University of Toronto study provides the first direct evidence ... filters our perceptual experience suggesting that seeing the world through ... and bad moods literally change the way our visual cortex ... of T professor of psychology. "Specifically our study shows ...
... An over-the-counter prostate cancer test kit could be coming to ... a University of Central Florida chemist and M.D. Anderson Cancer ... M.D. Anderson-Orlando,s Dr. Cheryl Baker and Jimmie Colon teamed up ... wanted to develop an effective, inexpensive test to screen for ...
... new review published in the Journal of Human Nutrition ... a beneficial effect on the prevention of prostate cancer. Results ... and high in fruits and vegetables is beneficial in preventing ... K. Chapman conducted an evidence-based review of dietary recommendations in ...
Cached Medicine News:Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 2Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 3Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 4Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 2Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 3Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 4Health News:Duke University Health System Chooses SSI for Revenue Cycle Claims Management 2Health News:Duke University Health System Chooses SSI for Revenue Cycle Claims Management 3Health News:People who wear rose-colored glasses see more, University of Toronto study shows 2Health News:Effective over-the-counter prostate cancer test kit likely in next few years 2
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... Aaron manufactures two groups of flexible ... sterile and non-sterile in three different sizes ... flexible shaft portion of the light). These ... additional light is needed., ,The second ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
Medicine Products: